EBP Compendium: Summary of Clinical Practice Guideline
European Federation of Neurological Societies; Movement Disorder Society - European Section; Stichting De Regenboog (the Netherlands)
Review of the Therapeutic Management of Parkinson's Disease. Report of a Joint Task Force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: Early (Uncomplicated) Parkinson's Disease.
Horstink, M., Tolosa, E., et al.
European Journal of Neurology, 13(11), 1170–85.
AGREE Rating: Highly Recommended
This is a review and corresponding guideline from the joint task force of the European Federation of Neurological Societies and the Movement Disorder Societies. The guideline provides recommendations for the management of early uncomplicated Parkinson’s disease. The target audience of this guideline includes all healthcare professionals involved in the management of individuals with Parkinson's disease. Recommendations are graded A, B, C, or “Good Practice Point” based on the strength of supporting evidence. Grade A recommendations are based on evidence from a Class I study or at least two Class II studies. Grade B recommendations are based on a Class II study or overwhelming Class III evidence and Grade C recommendations are based on at least two convincing class III studies. If evidence is lacking or less than a Level C, recommendations are based on expert opinion from the guideline developers (Good Practice Point).
- General Findings - “[S]peech therapy is possibly effective. However, the long-term benefits of these therapies remain to be proved” (Level C Evidence) (p. 1177).
- General Findings - "No scientific evidence supports or refutes the efficacy on non-pharmacological swallowing therapy for dysphagia in [Parkinson's disease] PD" (p. 1176).
Keywords: Parkinson's Disease
Access the Guideline
Added to Compendium: November 2011